Prescription Required
Brilinta 90mg Tablet 180s is used to thwart heart events, cerebrovascular incidents, or fatalities in people who suffered heart conditions or acute coronary syndrome. Furthermore, it's employed to hinder blood clump generation in patients equipped with coronary stents for managing ACS.
This tablet belongs to a medication category known as antiplatelet drugs. It stops platelets (a unique type of blood cell) from amassing and producing clumps that might instigate a heart event or stroke.
Remain adherent to Ticagrelor routinely as recommended by your physician, even if you feel healthy, to inhibit heart and blood vessel complications. Don't abort Ticagrelor unexpectedly without discussing it with your doctor, as it may intensify the jeopardy of heart event, cerebrovascular incident, or blood coagulates in stents.
Patients who've been prescribed this medication must strictly follow their healthcare professional's advice regarding the dosage and treatment span.
Prompt reporting of any lingering symptoms or negative repercussions is crucial.
Insufficient information is available; please seek guidance from a healthcare professional.
Insufficient information is available; please seek guidance from a healthcare professional.
Insufficient information is available; please seek guidance from a healthcare professional.
Insufficient information is available; please seek guidance from a healthcare professional.
It is recommended to regularly check liver function while using this.
Brilinta 90mg Tablet 180s serves as an antiplatelet drug that restrains the P2Y12 receptor, averting platelet activation catalysed by ADP. This mechanism shrinks platelet aggregation, thereby diminishing the chances of blood clot generation. Prominently deployed in warding off cardiovascular incidents, Ticagrelor furnishes antiplatelet influences without the need for metabolic activation, marking it as a crucial alternative for handling acute coronary disorders and lessening the frequency of thrombotic episodes.
A heart attack, or myocardial infarction, is a serious medical emergency where the blood flow to a part of the heart muscle is suddenly blocked, leading to insufficient oxygen. If blood flow isn''t quickly restored, the heart muscle starts to die. It differs from cardiac arrest, where the heart stops beating. Strokes, either ischemic (blocked blood flow) or hemorrhagic (brain bleeding), can result from similar cardiovascular issues.
Content Updated on
Thursday, 18 January, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA